Massimo Federico

8PUBLICATIONS
46CO-AUTHORS
Molecular targetsHaematologyLiquid biopsiesPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 02, 2026
Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Adrian Bogdan Tigu, Andrei Ivancuta, Ciprian Tomuleasa

|May 05, 2025
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study.

Maria Elena Cabrera, Monica Civallero, Yana Stepanishyna

|Nov 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.

Massimo Federico, Catherine Fortpied, Yana Stepanishyna

|Oct 26, 2023
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

Stefano Luminari, Alexander Fossa, Judith Trotman

|Jul 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer

Pageof 2

Frequent Collaborators

4 joint publications

Martin Hutchings

4 joint publications

Yana Stepanishyna

3 joint publications

Wouter Plattel

2 joint publications

Stefano Luminari